Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-04-05 10:55 am Sale |
2024-04-05 | 13D | NGM Biopharmaceuticals, Inc. NGM |
COLUMN GROUP L P | 1,000 100.000% |
-22,078,509![]() (-100.00%) |
Filing History |
2024-02-26 5:16 pm Unchanged |
2024-02-25 | 13D | NGM Biopharmaceuticals, Inc. NGM |
COLUMN GROUP L P | 22,079,509 26.700% |
0 (Unchanged) |
Filing History |
2023-12-29 4:05 pm Purchase |
2023-12-28 | 13D | NGM Biopharmaceuticals, Inc. NGM |
COLUMN GROUP L P | 22,079,509 26.700% |
1,094,533![]() (+5.22%) |
Filing History |
2022-06-10 4:14 pm Purchase |
2022-06-01 | 13D | NGM Biopharmaceuticals, Inc. NGM |
COLUMN GROUP L P | 20,984,976 26.500% |
1,951,343![]() (+10.25%) |
Filing History |
2022-02-11 4:34 pm Sale |
2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
COLUMN GROUP L P | 654,245 1.500% |
-6,101,636![]() (-90.32%) |
Filing History |
2022-02-03 5:23 pm Purchase |
2022-01-24 | 13D | NGM Biopharmaceuticals, Inc. NGM |
COLUMN GROUP L P | 19,033,633 24.500% |
1,378,422![]() (+7.81%) |
Filing History |
2021-02-12 6:16 pm Purchase |
2020-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
COLUMN GROUP L P | 6,755,881 17.400% |
6,755,881![]() (New Position) |
Filing History |
2021-02-12 6:14 pm Unchanged |
2020-12-31 | 13G | Constellation Pharmaceuticals, Inc. CNST |
COLUMN GROUP L P | 6,240,638 13.100% |
0 (Unchanged) |
Filing History |
2020-06-24 4:15 pm Purchase |
2020-06-19 | 13G | Constellation Pharmaceuticals, Inc. CNST |
COLUMN GROUP L P | 6,240,638 13.100% |
41,674![]() (+0.67%) |
Filing History |